Dermalogica®

Dermalogica®
SPL v1
SPL
SPL Set ID c9100083-55b0-4301-b031-e5f11f5b86e3
Route
TOPICAL
Published
Effective Date 2012-01-19
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Avobenzone (2.5 mL) Octinoxate (9.4 mL) Octisalate (6.25 mL) Oxybenzone (3.75 mL)
Inactive Ingredients
Water Medium-chain Triglycerides Isopropyl Isostearate Butylene Glycol Cetostearyl Alcohol Phenoxyethanol Shea Butter Polysorbate 60 Polyoxyl 20 Cetostearyl Ether Aminomethylpropanol Lavandin Oil Dihexadecyl Phosphate Ceteth-10 Phosphate Methylparaben Linalool, (+/-)- Propylparaben Chlorphenesin Lavandula Angustifolia Flowering Top Evening Primrose Oil Panthenol Alpha-tocopherol Acetate Hyaluronate Sodium Edetate Disodium Tocopherol Ascorbyl Palmitate

Identifiers & Packaging

Pill Appearance
Color: white
Marketing Status
OTC MONOGRAPH NOT FINAL Active Since 2005-11-01
Description

Avobenzone (2.0%), Octinoxate (7.5%), Octisalate (5.0%), Oxybenzone (3.0%).

Medication Information

Description

Avobenzone (2.0%), Octinoxate (7.5%), Octisalate (5.0%), Oxybenzone (3.0%).

Section 42229-5

Dermalogica, Dist.

Los Angeles, CA 90009 USA

Section 50566-9

If irritation develops, discontinue use.

Section 50567-7

Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Section 50570-1

Do not use on infants under 6 months old.

Warnings

For external use only, not to be swallowed.

Other Ingredients

Water, Caprylic/Capric Triglyceride, Isopropyl Isostearate, Butylene Glycol, Cetearyl Alcohol, Cetyl Dimethicone, Phenoxyethanol, Butyrospermum Parkii (Shea Butter), Polysorbate 60, Ceteareth-20, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aminomethyl Propanol, Lavandula Hybrida Oil, Dicetyl Phosphate, Ceteth-10 Phosphate, Methylparaben, Linalool, Propylparaben, Chlorphenesin, Lavandula Angustifolia (Lavender) Extract, Oenothera Biennis (Evening Primrose) Oil, Panthenol, Tocopheryl Acetate, Glycolipids, Sodium Hyaluronate, Carbomer, Disodium EDTA, Ascorbyl Tetraisopalmitate, Sodium DNA, Tocopherol, Ascorbyl Palmitate, Limonene.

Active Ingredients

Avobenzone (2.0%), Octinoxate (7.5%), Octisalate (5.0%), Oxybenzone (3.0%).

Principal Display Panel 125 Ml Tube Box

multivitamin

bodyblock

spf 20

DIN# 02290936

4.2 FL OZ / 125 ml e

dermalogica ®

Structured Label Content

Section 42229-5 (42229-5)

Dermalogica, Dist.

Los Angeles, CA 90009 USA

Section 50566-9 (50566-9)

If irritation develops, discontinue use.

Section 50567-7 (50567-7)

Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Section 50570-1 (50570-1)

Do not use on infants under 6 months old.

Warnings (warnings)

For external use only, not to be swallowed.

Other Ingredients (other ingredients)

Water, Caprylic/Capric Triglyceride, Isopropyl Isostearate, Butylene Glycol, Cetearyl Alcohol, Cetyl Dimethicone, Phenoxyethanol, Butyrospermum Parkii (Shea Butter), Polysorbate 60, Ceteareth-20, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aminomethyl Propanol, Lavandula Hybrida Oil, Dicetyl Phosphate, Ceteth-10 Phosphate, Methylparaben, Linalool, Propylparaben, Chlorphenesin, Lavandula Angustifolia (Lavender) Extract, Oenothera Biennis (Evening Primrose) Oil, Panthenol, Tocopheryl Acetate, Glycolipids, Sodium Hyaluronate, Carbomer, Disodium EDTA, Ascorbyl Tetraisopalmitate, Sodium DNA, Tocopherol, Ascorbyl Palmitate, Limonene.

Active Ingredients (active ingredients)

Avobenzone (2.0%), Octinoxate (7.5%), Octisalate (5.0%), Oxybenzone (3.0%).

Principal Display Panel 125 Ml Tube Box (PRINCIPAL DISPLAY PANEL - 125 ml Tube Box)

multivitamin

bodyblock

spf 20

DIN# 02290936

4.2 FL OZ / 125 ml e

dermalogica ®

Advanced Ingredient Data

Raw Label Data

All Sections (JSON)

Additional Information

Back to search View SPL set listing Open on DailyMed ↗

Source: dailymed · Ingested: 2026-02-15T11:55:24.427260 · Updated: 2026-03-14T22:52:58.895821